Schedule 13D ownership disclosure

Imprimis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 45323A102

Event date: 2021-04-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-009866
Form type
SC 13D/A
Filer
BAUM MARK L
CIK
CIK 1274282
Filed
Apr 27, 2021
Reporting period
Apr 25, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub